News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Chromatin, Inc. Licenses Gene Stacking Technology for Sugar cane to Syngenta Corporation
June 26, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CHICAGO--(BUSINESS WIRE)--Chromatin Inc. announced today that it has entered into an exclusive worldwide research and commercial license agreement with Syngenta Biotechnology Inc. for Chromatin’s proprietary gene stacking technology in sugar cane.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
MORE ON THIS TOPIC
Layoff Tracker
Inovio Slims Down as Lead Asset Nears Market
March 16, 2026
·
36 min read
·
BioSpace Editorial Staff
Earnings
Biotechs Report Regulatory Headaches, High-Stakes Catalysts During Q4 Earnings
March 13, 2026
·
5 min read
·
Annalee Armstrong
Rare diseases
Rare Disease Sales To Soar to $400B+ By 2032 as Small Molecules Resurgent: Evaluate
March 13, 2026
·
2 min read
·
Tristan Manalac
Earnings
Novo Holdings’ Assets Fell 34% in 2025 As Its Namesake Drugmaker Struggled
March 12, 2026
·
1 min read
·
Annalee Armstrong